Leukotriene modulators as therapeutic agents in asthma and other inflammatory diseases

被引：9

作者：

Bell, RL

Summers, JB

Harris, RR

机构：

[1] Abbott Discovery Research, Abbott Park, IL

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 32 | 1997年 / 32卷

关键词：

D O I：

10.1016/S0065-7743(08)61467-0

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

[No abstract available]

引用

页码：91 / 100

页数：10

共 94 条

[11]

CHABOTFLETCHER MC, 1995, J PHARMACOL EXP THER, V273, P1147

[12]

CHAPMAN KR, 1995, AM J RESP CRIT CARE, V152, pA215

[13]

CHAURET N, 1995, AM SOC PHARM EXP THE, V23, P1325

[14] ROLE OF LEUKOTRIENES REVEALED BY TARGETED DISRUPTION OF THE 5-LIPOXYGENASE GENE [J].

CHEN, XS ;

SHELLER, JR ;

JOHNSON, EN ;

FUNK, CD .

NATURE, 1994, 372 (6502) :179-182

[15]

COLLAWN C, 1992, AM J GASTROENTEROL, V87, P342

[16]

CUTHBERT NJ, 1991, ANN NY ACAD SCI, V629, P402

[17] EFFECT OF THE LEUKOTRIENE RECEPTOR ANTAGONIST MK-0679 ON BASE-LINE PULMONARY-FUNCTION IN ASPIRIN-SENSITIVE ASTHMATIC SUBJECTS [J].

DAHLEN, B ;

MARGOLSKEE, DJ ;

ZETTERSTROM, O ;

DAHLEN, SE .

THORAX, 1993, 48 (12) :1205-1210

[18] (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid: A high-affinity leukotriene B-4 receptor antagonist with oral antiinflammatory activity [J].

Daines, RA ;

Chambers, PA ;

Foley, JJ ;

Griswold, DE ;

Kingsbury, WD ;

Martin, LD ;

Schmidt, DB ;

Sham, KKC ;

Sarau, HM .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (19) :3837-3841

[19] THE EFFECT OF MK-0591, A NOVEL 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITOR, ON LEUKOTRIENE BIOSYNTHESIS AND ALLERGEN-INDUCED AIRWAY RESPONSES IN ASTHMATIC SUBJECTS IN-VIVO [J].

DIAMANT, Z ;

TIMMERS, MC ;

VANDERVEEN, H ;

FRIEDMAN, BS ;

DESMET, M ;

DEPRE, M ;

HILLIARD, D ;

BEL, EH ;

STERK, PJ .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) :42-51

[20]

DONNELLY A, 1993, J ALLERGY CLIN IMMUN, V91, P259

← 1 2 3 4 5 6 7 8 9 10 →